Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19

1.

Strain-time curve analysis by speckle tracking echocardiography in cardiac resynchronization therapy: Insight into the pathophysiology of responders vs. non-responders.

To AC, Benatti RD, Sato K, Grimm RA, Thomas JD, Wilkoff BL, Agler D, Popović ZB.

Cardiovasc Ultrasound. 2016 Apr 18;14(1):14. doi: 10.1186/s12947-016-0057-4.

2.

Developments in Cardiac Resynchronisation Therapy.

Lewis GF, Gold MR.

Arrhythm Electrophysiol Rev. 2015 Aug;4(2):122-8. doi: 10.15420/aer.2015.04.02.122.

3.

Cardiac Resynchronisation Therapy or MitraClip® Implantation for Patients with Severe Mitral Regurgitation and Left Bundle Branch Block?

Kienemund J, Kuck KH, Frerker C.

Arrhythm Electrophysiol Rev. 2014 Nov;3(3):190-3. doi: 10.15420/aer.2014.3.3.190. Epub 2014 Nov 29.

4.

Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy.

Hasselberg NE, Haugaa KH, Bernard A, Ribe MP, Kongsgaard E, Donal E, Edvardsen T.

Eur Heart J Cardiovasc Imaging. 2016 Mar;17(3):343-50. doi: 10.1093/ehjci/jev173. Epub 2015 Jul 11.

5.

Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Herz ND, Engeda J, Zusterzeel R, Sanders WE, O'Callaghan KM, Strauss DG, Jacobs SB, Selzman KA, Piña IL, Caños DA.

J Womens Health (Larchmt). 2015 Apr;24(4):261-71. doi: 10.1089/jwh.2014.4980. Epub 2015 Mar 20. Review.

7.

The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.

Gold MR, Daubert C, Abraham WT, Ghio S, St John Sutton M, Hudnall JH, Cerkvenik J, Linde C.

Heart Rhythm. 2015 Mar;12(3):524-30. doi: 10.1016/j.hrthm.2014.11.014. Epub 2014 Nov 15.

8.

Left ventricular diameter and risk stratification for sudden cardiac death.

Narayanan K, Reinier K, Teodorescu C, Uy-Evanado A, Aleong R, Chugh H, Nichols GA, Gunson K, London B, Jui J, Chugh SS.

J Am Heart Assoc. 2014 Sep 16;3(5):e001193. doi: 10.1161/JAHA.114.001193.

9.

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.

Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SD; Effective aNticoaGulation with factor xA next GEneration in AF-Thrombolysis In Myocardial Infarction 48 Echocardiographic Study Investigators.

Eur Heart J. 2014 Jun 7;35(22):1457-65. doi: 10.1093/eurheartj/eht500. Epub 2013 Dec 2.

10.
11.

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.

Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J, Sherfesee L, Wells GA, Tang AS.

Eur Heart J. 2013 Dec;34(46):3547-56. doi: 10.1093/eurheartj/eht290. Epub 2013 Jul 29. Review.

12.

Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.

Mathew J, Katz R, St John Sutton M, Dixit S, Gerstenfeld EP, Ghio S, Gold MR, Linde C, Shlipak MG, Deo R.

Eur J Heart Fail. 2012 Dec;14(12):1420-8. doi: 10.1093/eurjhf/hfs135. Epub 2012 Sep 6.

13.

Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy.

Friedman DJ, Altman RK, Orencole M, Picard MH, Ruskin JN, Singh JP, Heist EK.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):762-72. doi: 10.1161/CIRCEP.112.971101. Epub 2012 Jul 11.

14.

Temporary epicardial cardiac resynchronisation versus conventional right ventricular pacing after cardiac surgery: study protocol for a randomised control trial.

Russell SJ, Tan C, O'Keefe P, Ashraf S, Zaidi A, Fraser AG, Yousef ZR.

Trials. 2012 Feb 20;13:20. doi: 10.1186/1745-6215-13-20.

15.

Animal models of dyssynchrony.

Strik M, van Middendorp LB, Vernooy K.

J Cardiovasc Transl Res. 2012 Apr;5(2):135-45. doi: 10.1007/s12265-011-9336-5. Epub 2011 Dec 1. Review.

16.

Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.

Alpendurada F, Guha K, Sharma R, Ismail TF, Clifford A, Banya W, Mohiaddin RH, Pennell DJ, Cowie MR, McDonagh T, Prasad SK.

J Cardiovasc Magn Reson. 2011 Oct 31;13:68. doi: 10.1186/1532-429X-13-68.

17.

The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.

Gold MR, Birgersdotter-Green U, Singh JP, Ellenbogen KA, Yu Y, Meyer TE, Seth M, Tchou PJ.

Eur Heart J. 2011 Oct;32(20):2516-24. doi: 10.1093/eurheartj/ehr329. Epub 2011 Aug 29.

18.

Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials.

Wells G, Parkash R, Healey JS, Talajic M, Arnold JM, Sullivan S, Peterson J, Yetisir E, Theoret-Patrick P, Luce M, Tang AS.

CMAJ. 2011 Mar 8;183(4):421-9. doi: 10.1503/cmaj.101685. Epub 2011 Jan 31.

19.

Echocardiographic prediction of outcome after cardiac resynchronization therapy: conventional methods and recent developments.

Leenders GE, Cramer MJ, Bogaard MD, Meine M, Doevendans PA, De Boeck BW.

Heart Fail Rev. 2011 May;16(3):235-50. doi: 10.1007/s10741-010-9200-8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk